ArticleRheumatology advances in practice2026
900 patients evaluated within a median of 1 day from referral in a very early arthritis clinic in France.
Article in Rheumatology advances in practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: In order to fit with National Institute for Health and Care Excellence (NICE) guidelines on arthritis, we established a 'very early arthritis clinic' (v-EAC) to evaluate patients within 48 h of a medical referral for any suspected arthritis of <1-month duration. We describe the characteristics of patients referred to the v-EAC from 2 October 2023 to 1 October 2024. Methods: Delay of referral was recorded. A systematic and standardized clinical, biological and ultrasound evaluation of all consecutive patients was conducted. Patients and disease characteristics are described. Results: A total of 900 patients were evaluated within a median delay of 1 day after referral: 51% were women and the median age was 55 years (IQR 42-67). Among these patients, 37% were referred by emergency departments, 28% by rheumatologists, 18% by general practitioners and 17% by other specialists. For 46% of patients, it was the first episode of a swollen joint, with a median symptom duration of 14 days (IQR 5-44) and a mean number of 1.3 (s.d. 1.9) swollen joints. Inflammatory arthritis was confirmed in 63% of cases and diagnoses were flare of immune-mediated inflammatory disease (IMID)-related arthritis in 35% of cases (half of which represented the first manifestation of an IMID-related arthritis), crystal-related arthritis in 27% (mostly gout) and infectious disease in 8.0% (including 34 bursitis and 13 septic arthritis). Joint aspiration was performed in 414 patients (46%). Corticosteroid-derivative injections were administered to 31% of patients and hospitalization was required in 10% of cases [median stay 6 days (IQR 4-8)]. Conclusion: A dedicated care pathway can make the NICE guidelines regarding management of arthritis reachable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.